Act1 modulates autoimmunity through its dual functions in CD40L/BAFF and IL-17 signaling

Cytokine

Volumn 41, Issue 2, 2008, Pages 105-113

  Li, Xiaoxia ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Five; Four; One; Three; Two

Indexed keywords

ADAPTER MOLECULE ACT 1; B CELL ACTIVATING FACTOR; CD40 LIGAND; INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALITIS; AUTOIMMUNITY; B LYMPHOCYTE ACTIVATION; CARBOXY TERMINAL SEQUENCE; CELLULAR IMMUNITY; COLITIS; CYTOKINE PRODUCTION; HOST RESISTANCE; HUMORAL IMMUNITY; HYPERGAMMAGLOBULINEMIA; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOREGULATION; INFLAMMATORY DISEASE; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHADENOPATHY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; REVIEW; SJOEGREN SYNDROME; SPLENOMEGALY; T LYMPHOCYTE ACTIVATION; TH1 CELL;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTIBODY FORMATION; ANTIGENS, CD40; AUTOIMMUNITY; B-CELL ACTIVATING FACTOR; B-CELL ACTIVATION FACTOR RECEPTOR; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; ENZYME ACTIVATION; HUMANS; I-KAPPA B KINASE; INFLAMMATION; INTERLEUKIN-17; MODELS, BIOLOGICAL; NF-KAPPA B; RECEPTORS, INTERLEUKIN-1; RECEPTORS, INTERLEUKIN-17; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PEPTIDES AND PROTEINS;

MUS;

EID: 38849094491     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2007.09.015     Document Type: Review

References (91)

1. Akira S., Takeda K., and Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2 (2001) 675-680
2. Awane M., Andres P.G., Li D.J., and Reinecker H.C. NF-kappa B-inducing kinase is a common mediator of IL-17-, TNF-alpha-, and IL-1 beta-induced chemokine promoter activation in intestinal epithelial cells. J Immunol 162 (1999) 5337-5344
3. Banchereau J., Bazan F., Blanchard D., Briere F., Galizzi J.P., van Kooten C., et al. The CD40 antigen and its ligand. Annu Rev Immunol 12 (1994) 881-922
4. Batten M., Groom J., Cachero T.G., Qian F., Schneider P., Tschopp J., et al. BAFF mediates survival of peripheral immature B lymphocytes. J Exp Med 192 (2000) 1453-1466
5. Becher B., Bechmann I., and Greter M. Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain. J Mol Med 84 (2006) 532-543
6. Bettelli E., Baeten D., Jager A., Sobel R.A., and Kuchroo V.K. Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice. J Clin Invest 116 (2006) 2393-2402
7. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441 (2006) 235-238
8. Brink R. Regulation of B cell self-tolerance by BAFF. Semin Immunol 18 (2006) 276-283
9. Cao Z., Henzel W.J., and Gao X. IRAK: a kinase associated with the interleukin-1 receptor. Science 271 (1996) 1128-1131
10. Cao Z., Xiong J., Takeuchi M., Kurama T., and Goeddel D.V. TRAF6 is a signal transducer for interleukin-1. Nature 383 (1996) 443-446
11. Carson M.J., Doose J.M., Melchior B., Schmid C.D., and Ploix C.C. CNS immune privilege: hiding in plain sight. Immunol Rev 213 (2006) 48-65
12. Cassan C., and liblau R.S. Immune tolerance and control of CNS autoimmunity: from animal models to MS patients. J Neurochem (2006)
13. Chan O., and Shlomchik M.J. A new role for B cells in systemic autoimmunity: B cells promote spontaneous T cell activation in MRL-lpr/lpr mice. J Immunol 160 (1998) 51-59
14. Chan O.T., Hannum L.G., Haberman A.M., Madaio M.P., and Shlomchik M.J. A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J Exp Med 189 (1999) 1639-1648
15. Chang S.H., Park H., and Dong C. Act1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor. J Biol Chem 281 (2006) 35603-35607
16. Cheema G.S., Roschke V., Hilbert D.M., and Stohl W. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum 44 (2001) 1313-1319
17. Chen Y., Thai P., Zhao Y.H., Ho Y.S., DeSouza M.M., and Wu R. Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop. J Biol Chem 278 (2003) 17036-17043
18. Coope H.J., Atkinson P.G., Huhse B., Belich M., Janzen J., Holman M.J., et al. CD40 regulates the processing of NF-kappaB2 p100 to p52. EMBO J 21 (2002) 5375-5385
19. Cose S. T-cell migration: a naive paradigm?. Immunology 120 (2007) 1-7
20. Deng L., Wang C., Spencer E., Yang L., Braun A., You J., et al. Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103 (2000) 351-361
21. DiDonato J.A., Hayakawa M., Rothwarf D.M., Zandi E., and Karin M. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature 388 (1997) 548-554
22. Dong Y., and Benveniste E.N. Immune function of astrocytes. Glia 36 (2001) 180-190
23. Friese M.A., Montalban X., Willcox N., Bell J.I., Martin R., and Fugger L. The value of animal models for drug development in multiple sclerosis. Brain 129 (2006) 1940-1952
24. Gauld S.B., Merrell K.T., and Cambier J.C. Silencing of autoreactive B cells by anergy: a fresh perspective. Curr Opin Immunol 18 (2006) 292-297
25. Ghosh S., and Karin M. Missing pieces in the NF-kappaB puzzle. Cell 109 Suppl. (2002) S81-S96
26. Ghosh S., May M.J., and Kopp E.B. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16 (1998) 225-260
27. Gold R., Linington C., and Lassmann H. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129 (2006) 1953-1971
28. Grammer A.C., and Lipsky P.E. CD40-mediated regulation of immune responses by TRAF-dependent and TRAF-independent signaling mechanisms. Adv Immunol 76 (2000) 61-178
29. Gross J.A., Johnston J., Mudri S., Enselman R., Dillon S.R., Madden K., et al. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 404 (2000) 995-999
30. Harrington L.E., Hatton R.D., Mangan P.R., Turner H., Murphy T.L., Murphy K.M., et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6 (2005) 1123-1132
31. Hartupee J., Liu C., Novotny M., Li X., and Hamilton T. IL-17 enhances chemokine gene expression through mRNA stabilization. J Immunol 179 6 (2007) 4135-4141
32. He J.Q., Saha S.K., Kang J.R., Zarnegar B., and Cheng G. Specificity of TRAF3 in its negative regulation of the noncanonical NF-kappa B pathway. J Biol Chem 282 6 (2007) 3688-3694
33. Higuchi T., Aiba Y., Nomura T., Matsuda J., Mochida K., Suzuki M., et al. Cutting edge: ectopic expression of CD40 ligand on B cells induces lupus-like autoimmune disease. J Immunol 168 (2002) 9-12
34. Hjelmstrom P., Juedes A.E., Fjell J., and Ruddle N.H. B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization. J Immunol 161 (1998) 4480-4483
35. Hostager B.S., Haxhinasto S.A., Rowland S.L., and Bishop G.A. Tumor necrosis factor receptor-associated factor 2 (TRAF2)-deficient B lymphocytes reveal novel roles for TRAF2 in CD40 signaling. J Biol Chem 278 (2003) 45382-45390
36. Inoue D., Numasaki M., Watanabe M., Kubo H., Sasaki T., Yasuda H., et al. IL-17A promotes the growth of airway epithelial cells through ERK dependent signaling pathway. Biochem Biophys Res Commun 347 (2006) 852-858
37. Iwakura Y., and Ishigame H. The IL-23/IL-17 axis in inflammation. J Clin Invest 116 (2006) 1218-1222
38. Karin M., and Ben Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol 18 (2000) 621-663
39. Kayagaki N., Yan M., Seshasayee D., Wang H., Lee W., French D.M., et al. BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2. Immunity 17 (2002) 515-524
40. Khare S.D., Sarosi I., Xia X.Z., McCabe S., Miner K., Solovyev I., et al. Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. Proc Natl Acad Sci USA 97 (2000) 3370-3375
41. Koenders M.I., Kolls J.K., Oppers-Walgreen B., van den B.L., Joosten L.A., Schurr J.R., et al. Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis. Arthritis Rheum 52 (2005) 3239-3247
42. Kolls J.K., and Linden A. Interleukin-17 family members and inflammation. Immunity 21 (2004) 467-476
43. Laabi Y., and Strasser A. Immunology. Lymphocyte survival-ignorance is BLys. Science 289 (2000) 883-884
44. Leonardi A., Chariot A., Claudio E., Cunningham K., and Siebenlist U. CIKS, a connection to Ikappa B kinase and stress-activated protein kinase. Proc Natl Acad Sci USA 97 (2000) 10494-10499
45. Li S., Strelow A., Fontana E.J., and Wesche H. IRAK-4: a novel member of the IRAK family with the properties of an IRAK-kinase. Proc Natl Acad Sci USA 99 (2002) 5567-5572
46. Li X., Commane M., Burns C., Vithalani K., Cao Z., and Stark G.R. Mutant cells that do not respond to interleukin-1 (IL-1) reveal a novel role for IL-1 receptor-associated kinase. Mol Cell Biol 19 (1999) 4643-4652
47. Li X., Commane M., Nie H., Hua X., Chatterjee-Kishore M., Wald D., et al. Act1, an NF-kappa B-activating protein. Proc Natl Acad Sci USA 97 (2000) 10489-10493
48. Li X., and Stark G.R. NFkappaB-dependent signaling pathways. Exp Hematol 30 (2002) 285-296
49. Li Z.W., Omori S.A., Labuda T., Karin M., and Rickert R.C. IKK beta is required for peripheral B cell survival and proliferation. J Immunol 170 (2003) 4630-4637
50. Liang L., Porter E.M., and Sha W.C. Constitutive expression of the B7h ligand for inducible costimulator on naive B cells is extinguished after activation by distinct B cell receptor and interleukin 4 receptor-mediated pathways and can be rescued by CD40 signaling. J Exp Med 196 (2002) 97-108
51. Mackay F., Schneider P., Rennert P., and Browning J. BAFF AND APRIL: a tutorial on B cell survival. Annu Rev Immunol 21 (2003) 231-264
52. Mackay F., Woodcock S.A., Lawton P., Ambrose C., Baetscher M., Schneider P., et al. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med 190 (1999) 1697-1710
53. Mangan P.R., Harrington L.E., O'Quinn D.B., Helms W.S., Bullard D.C., Elson C.O., et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441 (2006) 231-234
54. Medzhitov R., Preston-Hurlburt P., and Janeway Jr. C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388 (1997) 394-397
55. Mercurio F., Zhu H., Murray B.W., Shevchenko A., Bennett B.L., Li J., et al. IKK-1 and IKK-2: cytokine activated IkappaB kinases essential for NF-kappaB activation. Science 278 (1997) 860-866
56. Mitcham J.L., Parnet P., Bonnert T.P., Garka K.E., Gerhart M.J., Slack J.L., et al. T1/ST2 signaling establishes it as a member of an expanding interleukin-1 receptor family. J Biol Chem 271 (1996) 5777-5783
57. Nakae S., Komiyama Y., Nambu A., Sudo K., Iwase M., Homma I., et al. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17 (2002) 375-387
58. Novatchkova M., Leibbrandt A., Werzowa J., Neubuser A., and Eisenhaber F. The STIR-domain superfamily in signal transduction, development and immunity. Trends Biochem Sci 28 (2003) 226-229
59. Pagan A.J., Ramon H.E., Hondowicz B.D., and Erikson J. T cell-mediated activation and regulation of anti-chromatin B cells. Autoimmun Rev 5 (2006) 373-376
60. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6 (2005) 1133-1141
61. Pasparakis M., Schmidt-Supprian M., and Rajewsky K. IkappaB kinase signaling is essential for maintenance of mature B cells. J Exp Med 196 (2002) 743-752
62. Picard C., Puel A., Bonnet M., Ku C.L., Bustamante J., Yang K., et al. Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 299 (2003) 2076-2079
63. Qian Y., Liu C., Hartupee J., Altuntas C.Z., Gulen M.F., Jane-wit D., Xiao J., Lu Y., Giltiay N., Liu J., Kordula T., Zhang Q., Vallance B., Swaidani S., Aronica M., Tuohy V., Hamilton T., and Li X. Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat Immunol 8 3 (2007) 247-256
64. Qian Y., Qin J., Cui G., Naramura M., Snow E.C., Ware C.F., et al. Act1, a negative regulator in. Immunity 21 (2004) 575-587
65. Qian Y., Zhao Z., Jiang Z., and Li X. Role of NF kappa B activator Act1 in CD40-mediated signaling in epithelial cells. Proc Natl Acad Sci USA 99 (2002) 9386-9391
66. Regnier C.H., Song H.Y., Gao X., Goeddel D.V., Cao Z., and Rothe M. Identification and characterization of an IkappaB kinase. Cell 90 (1997) 373-383
67. Rizzi M., Ferrera F., Filaci G., and Indiveri F. Disruption of immunological tolerance: role of AIRE gene in autoimmunity. Autoimmun Rev 5 (2006) 145-147
68. Rolink A.G., Tschopp J., Schneider P., and Melchers F. BAFF is a survival and maturation factor for mouse B cells. Eur J Immunol 32 (2002) 2004-2010
69. Ruddy M.J., Wong G.C., Liu X.K., Yamamoto H., Kasayama S., Kirkwood K.L., et al. Functional cooperation between interleukin-17 and tumor necrosis factor-alpha is mediated by CCAAT/enhancer-binding protein family members. J Biol Chem 279 (2004) 2559-2567
70. Rudensky A.Y., Gavin M., and Zheng Y. FOXP3 and NFAT: partners in tolerance. Cell 126 (2006) 253-256
71. Sato S., Sanjo H., Takeda K., Ninomiya-Tsuji J., Yamamoto M., Kawai T., et al. Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat Immunol (2005)
72. Schiemann B., Gommerman J.L., Vora K., Cachero T.G., Shulga-Morskaya S., Dobles M., et al. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 293 (2001) 2111-2114
73. Schnyder-Candrian S., Togbe D., Couillin I., Mercier I., Brombacher F., Quesniaux V., et al. Interleukin-17 is a negative regulator of established allergic asthma. J Exp Med 203 (2006) 2715-2725
74. Schwandner R., Yamaguchi K., and Cao Z. Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction. J Exp Med 191 (2000) 1233-1240
75. Shim J.H., Xiao C., Paschal A.E., Bailey S.T., Rao P., Hayden M.S., et al. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev 19 (2005) 2668-2681
76. Steinman L. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 85 (1996) 299-302
77. Suzuki N., Suzuki S., Duncan G.S., Millar D.G., Wada T., Mirtsos C., et al. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature 416 (2002) 750-756
78. Toy D., Kugler D., Wolfson M., Bos T.V., Gurgel J., Derry J., et al. Cutting edge: interleukin 17 signals through a heteromeric receptor complex. J Immunol 177 (2006) 36-39
79. Trajkovic V., Stosic-Grujicic S., Samardzic T., Markovic M., Miljkovic D., Ramic Z., et al. Interleukin-17 stimulates inducible nitric oxide synthase activation in rodent astrocytes. J Neuroimmunol 119 (2001) 183-191
80. Ubogu E.E., Cossoy M.B., and Ransohoff R.M. The expression and function of chemokines involved in CNS inflammation. Trends Pharmacol Sci 27 (2006) 48-55
81. van Kooten C., and Banchereau J. Functional role of CD40 and its ligand. Int Arch Allergy Immunol 113 (1997) 393-399
82. Veldhoen M., Hocking R.J., Atkins C.J., Locksley R.M., and Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24 (2006) 179-189
83. Ware C.F. APRIL and BAFF connect autoimmunity and cancer. J Exp Med 192 (2000) F35-F38
84. Weaver A., Goncalves d.S., Nuttall R.K., Edwards D.R., Shapiro S.D., Rivest S., et al. An elevated matrix metalloproteinase (MMP) in an animal model of multiple sclerosis is protective by affecting Th1/Th2 polarization. FASEB J 19 (2005) 1668-1670
85. Woronicz J.D., Gao X., Cao Z., Rothe M., and Goeddel D.V. IkappaB kinasebeta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK. Science 278 (1997) 866-869
86. Xu L.G., and Shu H.B. TNFR-associated factor-3 is associated with BAFF-R and negatively regulates BAFF-R-mediated NF-kappa B activation and IL-10 production. J Immunol 169 (2002) 6883-6889
87. Yao Z., Spriggs M.K., Derry J.M., Strockbine L., Park L.S., VandenBos T., et al. Molecular characterization of the human interleukin (IL)-17 receptor. Cytokine 9 (1997) 794-800
88. Youinou P., Hillion S., Jamin C., Pers J.O., Saraux A., and Renaudineau Y. B lymphocytes on the front line of autoimmunity. Autoimmun Rev 5 (2006) 215-221
89. Zandi E., Rothwarf D.M., Delhase M., Hayakawa M., and Karin M. The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell 91 (1997) 243-252
90. Zhang J., Roschke V., Baker K.P., Wang Z., Alarcon G.S., Fessler B.J., et al. Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus. J Immunol 166 (2001) 6-10
91. Zhang Z., Zheng M., Bindas J., Schwarzenberger P., and Kolls J.K. Critical role of IL-17 receptor signaling in acute TNBS-induced colitis. Inflamm Bowel Dis 12 (2006) 382-388